571 | For those unable to swallow or tolerate solid oral dosage form AND
For the treatment of Cytomegalovirus (CMV) retinitis in patients with HIV/AIDS. |
| LU Authorization Period: 1 year |
572 | For those unable to swallow or tolerate solid oral dosage form AND
For the prevention of Cytomegalovirus (CMV) in solid organ transplant patients (not lung or heart-lung). |
| LU Authorization Period: Up to 6 months |
573 | For those unable to swallow or tolerate solid oral dosage form AND
For the prevention of Cytomegalovirus (CMV) in lung or heart-lung transplant patients. |
| LU Authorization Period: Up to 12 months |